My Account | Shopping Cart | Contact  
Trilink Biotech Logo

Oligonucleotides | mRNA & Long RNA | Nucleotides | CleanCap® | CleanTag® | CleanAmp® | Custom Chemistry | cGMP

OligoBuilder® | Nucleotides List | Stocked mRNA List | DNA Synthesis Reagents List | CleanAmp™ Products List

You are at: All > Oligonucleotides > Custom Oligonucleotide Components > Custom Oligonucleotide Components by Type > Backbones (Purification Options & Expected Yields)

2' Fluoro RNA
2' F RNA

2' Fluoro RNA

Per Base Pyrimidine Pricing (C/U)
5.0 µmole Inquire*
10 µmole Inquire*
15 µmole Inquire*
*2' Fluoro pricing at selected scales is based on the number of incorporations in your oligonucleotide.

Per Base Purine Pricing (A/G)
5.0 µmole $175.00
10 µmole $250.00
15 µmole $350.00

Per base pricing discounted for multiple incorporations. Minimum pricing requirements may apply. Please request a quote for exact pricing or contact us to speak with a customer service representative.

Purification Methods and Expected Yields
2' Fluoro RNA oligonucleotides can often be purified using the same methods as standard DNA oligonucleotides. However, this depends on the design of the entire molecule. Yields are extremely variable, affected by modifications and sequence. Please contact us for information regarding purification methods and expected yields for your specific construct.

The main applications of this modification are ribozyme development - to increase Tm, aptamer selection, and nuclease resistance. A substitution of 2’-fluoro for 2’-hydroxyl group in a RNA monomer does not substantially change the conformation of sugar ring puckering and other structural parameters thus making 2’-deoxy-2’-fluoro RNA oligonucleotide analogs (FRNA) a virtual mimic of natural RNAs. FRNA and RNA have many similar physical properties which allow FRNAs to form stable duplexes with RNA targets. The stability of FRNA-RNA duplexes is even higher than that for normal RNA-RNA duplexes (about 1-2oC per each substitution ). With DNA targets there is a moderate increase of Tm for DNA-FRNA duplexes (up to 1oC per substitution) compared to normal DNA-DNA duplexes.   Oligonucleotides containing 2’ fluoros have been reported to increase DNA-DNA Tm by 1.3°C per insertion.

The absence of the 2’-hydroxyl group makes the internucleotide linkages in oligonucleotides with 2’-deoxy-2’-fluoro much more stable to a chemical hydrolysis at ahigh pH compared to internucleotide linkages in unmodified RNA oligonucleotides. The increased chemical stability of 2’-deoxy-2’-fluoro RNA oligonucleotide analogs is accompanied by high resistance of 2’-deoxy-2’-fluoro linkages to ribonucleases and, consequently, leads to a longer survival time of FRNAs in biological environment (cell cultures, plasma, animals, etc.).

The biological activity of siRNAs constructed from 2’-deoxy-2’-fluoro units in cell culture systems and in vivo is similar or higher compared to activity of unmodified RNAs. Notably, siRNAs containing 2’-deoxy-2’-fluoro units have lower level of activation of immune response compared to unmodified siRNAs. However, duplexes of FRNA and RNA do not support RNAse H activity and therefore the use of FRNA oligonucleotides is questionable for antisense applications.

In addition, 2’-deoxy-2’-fluoro RNA analogs have been used in the construction and studies of ribozymes and oligonucleotide aptamers with enhanced affinity.

Email a Friend
Product Inquiry
Ready to order
your oligonucleotide?

Related Products :

Related Categories :

Kumudha A, Selvakumar S, Dilshad P, Vaidyanathan G, Thakur MS, Sarada R. Methylcobalamin – A form of vitamin B12 identified and characterised in Chlorella vulgaris. Food Chemistry, 170, 1 March 2015, 316-320
Hernandez FJ, Stockdale KR, Huang L, Horswill AR, Behlke MA, McNamara JO. Degradation of Nuclease-Stabilized RNA Oligonucleotides in Mycoplasma-Contaminated Cell Culture Media. Nucleic Acid Ther. 2012 Jan 9. doi: 10.1089/nat.2011.0316.
Shu D, Shu Y, Haque F, Abdelmawla S, Guo P. Thermodynamically stable RNA three-way junction for constructing multifunctional nanoparticles for delivery of therapeutics. (2011) Nature Nanotechnology, doi: 10.1038/nnano.2011.105. [Epub ahead of print]
Manoharan M, et. al. Unique gene-silencing and structural properties of 2'-fluoro-modified siRNAs. Angew Chem Int Ed Engl. 2011 Mar 1;50(10):2284-8.
Pallan PS, Greene EM, Jicman PA, Pandey RK, Manoharan M, Rozners E, Egli M. Unexpected origins of the enhanced pairing affinity of 2'-fluoro-modified RNA. Nucleic Acids Res. 2011 Apr;39(8):3482-95.
Blidner RA, Hammer RP, Lopez MJ, Robinson SO, Monroe WT. Fully 2'-deoxy-2'-fluoro substituted nucleic acids induce RNA interference in mammalian cell culture. Chem Biol Drug Des. 2007 Aug;70(2):113-22.
Morrissey DV, et. al. Potent and persistent in vivo anti-HBV activity of chemically modified siRNAs. Nat Biotechnol. 2005 Aug;23(8):1002-7.
Layzer JM, McCaffrey AP, Tanner AK, Huang Z, Kay MA, Sullenger BA. In vivo activity of nuclease-resistant siRNAs. RNA. 2004 May;10(5):766-71.
Khati M, Schüman M, Ibrahim J, Sattentau Q, Gordon S, James W. Neutralization of infectivity of diverse R5 clinical isolates of human immunodeficiency virus type 1 by gp120-binding 2'F-RNA aptamers. J Virol. 2003 Dec;77(23):12692-8.
Chiu YL, Rana TM. siRNA function in RNAi: a chemical modification analysis. RNA. 2003 Sep;9(9):1034-48.
Rhie A, Kirby L, Sayer N, Wellesley R, Disterer P, Sylvester I, Gill A, Hope J, James W, Tahiri-Alaoui A. Characterization of 2'-fluoro-RNA aptamers that bind preferentially to disease-associated conformations of prion protein and inhibit conversion. J Bi
Yazbeck DR, Min KL, Damha MJ. Molecular requirements for degradation of a modified sense RNA strand by Escherichia coli ribonuclease H1. Nucleic Acids Res. 2002 Jul 15;30(14):3015-25.
Sabahi A, Guidry J, Inamati GB, Manoharan M, Wittung-Stafshede P. Hybridization of 2'-ribose modified mixed-sequence oligonucleotides: thermodynamic and kinetic studies. Nucleic Acids Res. 2001 May 15;29(10):2163-70.
Ruckman J, Green LS, Beeson J, Waugh S, Gillette WL, Henninger DD, Claesson-Welsh L, Janjić N. 2'-Fluoropyrimidine RNA-based aptamers to the 165-amino acid form of vascular endothelial growth factor (VEGF165). J Biol Chem. 1998 Aug 7;273(32):20556-67.
Fell PL, Hudson AJ, Reynolds MA, Usman N, Akhtar S. Cellular uptake properties of a 2'-amino/2'-O-methyl-modified chimeric hammerhead ribozyme targeted to the epidermal growth factor receptor mRNA. Antisense Nucleic Acid Drug Dev. 1997 Aug;7(4):319-26.
Kubik MF, Bell C, Fitzwater T, Watson SR, Tasset DM. Isolation and characterization of 2'-fluoro-, 2'-amino-, and 2'-fluoro-/amino-modified RNA ligands to human IFN-gamma that inhibit receptor binding. J Immunol. 1997 Jul 1;159(1):259-67.
Beigelman L, et. al. Chemical modification of hammerhead ribozymes. Catalytic activity and nuclease resistance. J Biol Chem. 1995 Oct 27;270(43):25702-8.
Kawasaki AM, et. al. Uniformly modified 2'-deoxy-2'-fluoro phosphorothioate oligonucleotides as nuclease-resistant antisense compounds with high affinity and specificity for RNA targets. J Med Chem. 1993 Apr 2;36(7):831-41.
Pieken WA, Olsen DB, Benseler F, Aurup H, Eckstein F. Kinetic characterization of ribonuclease-resistant 2'-modified hammerhead ribozymes. Science. 1991 Jul 19;253(5017):314-7.



  Twitter Twitter Facebook Facebook Linked In Linked In RSS RSS Google RSS  
© 2019 TriLink BioTechnologies, LLC | All Rights Reserved